Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,931 | 43,200 | 39,520 | 46,880 | 31,990 |
| Marketable Securities | N/A | 0 | 0 | 0 | 1,930 |
| Receivables | 867 | 1,950 | 7,990 | 7,710 | 4,550 |
| Inventories | N/A | 0 | 4,080 | 3,450 | 3,310 |
| Other current assets | 0 | 500 | 1,710 | 2,090 | 2,390 |
| TOTAL | $36,217 | $45,650 | $53,300 | $60,130 | $44,170 |
| Non-Current Assets | |||||
| PPE Net | 797 | 1,350 | 2,140 | 2,510 | 3,090 |
| Intangibles | 9,039 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,382 | 12,190 | 12,210 | 12,710 | 29,290 |
| TOTAL | $11,218 | $13,540 | $14,350 | $15,220 | $32,380 |
| Total Assets | $47,435 | $59,190 | $67,660 | $75,360 | $76,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 50 | 60 |
| Accounts payable and accrued liabilities | 5,799 | 7,240 | 6,670 | 8,060 | 6,380 |
| Accrued Expenses | N/A | 0 | 3,760 | 3,170 | 2,990 |
| Other current liabilities | 1,505 | 0 | 5,260 | 6,330 | 4,040 |
| TOTAL | $7,574 | $7,240 | $15,700 | $17,880 | $13,480 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | 0 | 90 |
| Deferred Revenues | 270 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 24,568 | 34,890 | 23,990 | 22,780 | 11,500 |
| TOTAL | $25,377 | $34,890 | $58,650 | $62,020 | $50,640 |
| Total Liabilities | $32,951 | $42,130 | $74,360 | $79,910 | $64,130 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7 | 5 | 3 | N/A | N/A |
| Common Shares | 150,544 | 134,100 | 122,790 | 101,880 | 60,140 |
| Retained earnings | -222,322 | -203,920 | -213,080 | -188,960 | -150,750 |
| Other shareholders' equity | 86,262 | 86,880 | 83,600 | 82,540 | 103,040 |
| TOTAL | $14,484 | $17,060 | $-6,690 | $-4,540 | $12,430 |
| Total Liabilities And Equity | $47,435 | $59,190 | $67,670 | $75,370 | $76,560 |